NEFL and Spinocerebellar ataxia type 3: These findings provide information on NfL biofluid changes in the YACQ84 mouse, validating the neurodegenerative biomarkers in this frequently used SCA3 preclinical model and indicating increased opportunity for use of biomarkers in future preclinical SCA3 trials.